| Cash Flow | 2025-09-30 |
|---|---|
| Net income (loss) from continuing operations | 580,888 |
| Depreciation and amortization | 8,307 |
| Stock-based compensation | 49,250 |
| Realized loss on sale/purchase of digital assets | 0 |
| Loss on settlement of payables | 0 |
| Loss on exchange of series c & d preferred stock | -241,918 |
| Lease cost, net of repayment | 7,550 |
| Change in fair value of digital assets | 0 |
| Receivables | -287 |
| Prepaid expenses and other current assets | 1,244 |
| Accounts payable | -27,655 |
| Accrued expenses | 13,309 |
| Deferred revenue | -203 |
| Due to related party | 118,588 |
| Net cash provided by (used in) operating activities - continuing | -170,781 |
| Net cash provided by (used in) operating activities - discontinuing | 0 |
| Net cash provided by (used in) operating activities | -170,781 |
| Cash acquired in acquisition of healthy lifestyle usa llc | 0 |
| Purchase of 51 interest in healthy lifestyle usa llc | 0 |
| Net proceeds from the sale of digital assets | 0 |
| Purchase of digital assets | 0 |
| Purchase of leasehold improvements | 7,308 |
| Purchase of intangible assets | 0 |
| Cash deposit received from subtenant | 0 |
| Net cash provided by (used in) investing activities - continuing | -7,308 |
| Net cash provided by (used in) investing activities - discontinuing | 0 |
| Net cash provided by (used in) investing activities | -7,308 |
| Repayment of accrued interest on note payable | 0 |
| Repayment of related party advance | 0 |
| Net cash provided by (used in) financing activities - continuing | 0 |
| Net cash provided by (used in) financing activities - discontinuing | 0 |
| Net cash provided by (used in) financing activities | 0 |
| Net increase (decrease) in cash | -178,089 |
| Cash and cash equivalents at beginning of period | 401,310 |
| Cash and cash equivalents at end of period | 223,221 |
MedWellAI, Inc. (MWAI)
MedWellAI, Inc. (MWAI)